57/100

Moderate evidence

Cite
More
EmailLinkedInX

AI reading 500 cell images per patient sorts leukemia subtypes with 88% accuracy in a test

Study title: Person-Based Progression in Acute Myeloid Leukemia Classification: A Multi-View Convolutional Neural Network Approach

Evidence type
Benchmark or lab evaluation
Sample
n = 81,214
Sources
1 sourcePeer-reviewed
Published
1 min read

Study title: Person-Based Progression in Acute Myeloid Leukemia Classification: A Multi-View Convolutional Neural Network Approach

By the publication date of 2026-10-01, researchers had developed and evaluated a person-based multi-view CNN approach for AML subtype classification using 81,214 single-cell images from 189 individuals. The 500-view MV-CNN achieved accuracy 0.8783, F1 0.8622, sensitivity 0.8637, specificity 0.8774, precision 0.8616 and MCC 0.8441, outperforming a single-view CNN baseline in tenfold cross-validation.

Read the study abstract

Acute myeloid leukemia (AML) is a hematologic malignancy in which accurate subtype identification is important for treatment planning and prognosis. This study developed a deep learning approach for AML subtype classification using multiple single-cell images from each patient rather than conventional instance-based classification. An open-source dataset containing 81,214 single-cell images from 189 individuals was analyzed. The dataset included four genetically defined AML subtypes and a healthy control group.…

Person-Based Progression in Acute Myeloid Leukemia Classification: A Multi-View Convolutional Neural Network Approach
Canine piroplasmosis Plate IX Nuttall 1905 14 15 by Nuttall, George Henry Falkiner, 1862-1937. Public domain

The gain

In tenfold cross-validation on 81,214 cell images from 189 people, the 500-view model reached 0.8783 accuracy and 0.8622 F1, beating a single-image CNN baseline that scored lowest.

In brief

The result matters because accurate subtype identification is important for treatment planning and prognosis in AML, and patient-level aggregation of multiple cell images improved classification over conventional instance-based analysis. What remains uncertain is clinical translation, as the source describes performance on an open-source dataset and supports potential for hematologic image classification rather than reporting prospective clinical deployment or patient outcomes.

Main points

  1. Study used open-source dataset of 81,214 single-cell images from 189 individuals covering four genetically defined AML subtypes and healthy controls.
  2. Two MV-CNN models were tested: 99-view model based on random sampling and 500-view model using image augmentation when fewer than 500 images were available per patient.
  3. Performance assessed by tenfold cross-validation on accuracy, F1, sensitivity, specificity, precision, and MCC; single-view CNN yielded the lowest values.

The full story

The comparison was a single-view CNN versus two multi-view approaches, with the 99-view model showing lower but comparable performance to the 500-view model.

Dataset included four genetically defined AML subtypes plus a healthy control group, and evaluation used tenfold cross-validation across six metrics including Matthews correlation coefficient.

Sources

1 on file
  1. Journal of Imaging Informatics in Medicinedoi:10.1007/s10278-026-02371-7
    Peer-reviewed2026-10-01

Talk it over

Three questions to start on, two more if you have time
The 500-view model reached 0.8783 accuracy and beat the single-view CNN across the metrics. What does that tell you about using many cell images per person rather than one?

Start with a question

AI reading 500 cell images per patient sorts leukemia subtypes with 88% accuracy in a testhttps://truvace.com/item/person-based-progression-in-acute-myeloid-leukemia-classification-a-multi-view-c

  1. The 500-view model reached 0.8783 accuracy and beat the single-view CNN across the metrics. What does that tell you about using many cell images per person rather than one?

    Answer in the thread
  2. The data came from an open-source dataset of 81,214 images from 189 individuals. Who or what might be missing from that sample, and how could it change the results in a clinic?

    Answer in the thread
  3. The source reports no prospective clinical deployment or patient outcomes. What would you want to see from a real hospital trial before relying on this for AML treatment planning?

    Answer in the thread
If you have more time
  • The 99-view model performed lower but comparable to the 500-view model. What would you look up to judge whether the extra views are worth the added effort?

    Answer in the thread
  • If you were a patient with suspected AML, how would you want a doctor to describe the role of this kind of image classification in your care?

    Answer in the thread

What readers say